Peter A. Virsik
21Patents
7h-index
24Co-inventors
65Inventor score
Filing activity: Sep 5, 2008 → Dec 5, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8778991B2 | Prodrugs of methyl hydrogen fumarate, pharmaceutical compositions thereof, and methods of use | Chemistry; Metallurgy | 65 | Active |
| US8148414B2 | Prodrugs of methyl hydrogen fumarate, pharmaceutical compositions thereof, and methods of use | Chemistry; Metallurgy | 45 | Active |
| US8168617B2 | Complex pantoic acid ester neopentyl sulfonyl ester cyclization release prodrugs of acamprosate, compositions thereof, and methods of use | Human Necessities | 18 | Active |
| US8785443B2 | Methods of using prodrugs of methyl hydrogen fumarate and pharmaceutical compositions thereof | Chemistry; Metallurgy | 13 | Active |
| US7994218B2 | Simple pantoic acid ester neopentyl sulfonyl ester cyclization release prodrugs of acamprosate, compositions thereof, and methods of use | Human Necessities | 10 | Active |
| US11059795B2 | Androgen receptor modulators and methods for their use | Chemistry; Metallurgy | 8 | Active |
| US11242324B2 | Solid forms of an n-terminal domain androgen receptor inhibitor and uses thereof | Chemistry; Metallurgy | 7 | Active |
| US11485713B2 | Androgen receptor modulators and methods for their use | Chemistry; Metallurgy | 7 | Active |
| US11358938B2 | Solid forms of an N-terminal domain androgen receptor inhibitor and uses thereof | Chemistry; Metallurgy | 5 | Active |
| US11518747B2 | Solid forms of an N-terminal domain androgen receptor inhibitor and uses thereof | Chemistry; Metallurgy | 4 | Active |
| US7868043B2 | Mesophasic forms of (3S)-aminomethyl-5-methyl-hexanoic acid prodrugs and methods of use | Chemistry; Metallurgy | 4 | Active |
| US7872046B2 | Crystalline form of a (3S)-aminomethyl-5-methyl-hexanoic acid prodrug and methods of use | Chemistry; Metallurgy | 1 | Active |
| US12109179B2 | Pharmaceutical compositions and combinations comprising inhibitors of the androgen receptor and uses thereof | Human Necessities | 0 | Active |
| US11814357B2 | Solid forms of an N-terminal domain androgen receptor inhibitor and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US8258179B2 | Crystalline form of a (3S)-aminomethyl-5-methyl-hexanoic acid prodrug and methods of use | Chemistry; Metallurgy | 0 | Active |
| US10624340B2 | Chemical combinations for attracting Vespidae | Human Necessities | 0 | Active |
| US9452972B2 | Methods of using prodrugs of methyl hydrogen fumarate and pharmaceutical compositions thereof | Chemistry; Metallurgy | 0 | Active |
| US10940117B2 | Oral dosage forms of methyl hydrogen fumarate and prodrugs thereof | Emerging Cross-Sectional Technologies | 0 | Active |
| US9597292B2 | Oral dosage forms of methyl hydrogen fumarate and prodrugs thereof | Emerging Cross-Sectional Technologies | 0 | Active |
| US10945984B2 | Methods of administering monomethyl fumarate and prodrugs thereof having reduced side effects | Human Necessities | 0 | Active |
| US10716760B2 | Oral dosage forms of methyl hydrogen fumarate and prodrugs thereof | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.